Alterations in polyamine catabolic enzymes in human breast cancer tissue

H M Wallace, J Duthie, D M Evans, S Lamond, K M Nicoll, S D Heys

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

High concentrations of acetyl polyamines have been observed in human breast cancer compared with the equivalent normal tissue, however, no explanation as to the reason for the increases has been proposed. In this study, we show that changes in the enzymes responsible for the breakdown of acetyl polyamines occur in breast cancer tissue. Spermidine/spermine N-1-acetyltranferase, the first and rate-limiting enzyme in polyamine catabolism, is increased in the tumor tissue whereas polyamine oxidase (PAO) is decreased. The changes in PAO correlate with prognostic factors, and activity decreases as the size and histological grade of tumors increase. The metabolism of polyamines by PAO generates locally high concentrations of hydrogen peroxide, a known inducer of apoptosis; thus, low PAO activity may contribute to the low level of apoptosis seen in tumor cells. Therefore, drugs that induce PAO activity may be a novel means of attacking tumor cells.

Original languageEnglish
Pages (from-to)3657-3661
Number of pages5
JournalClinical Cancer Research
Volume6
Publication statusPublished - 2000

Keywords

  • CELLS
  • DERIVATIVES
  • ACETYLATION

Cite this

Wallace, H. M., Duthie, J., Evans, D. M., Lamond, S., Nicoll, K. M., & Heys, S. D. (2000). Alterations in polyamine catabolic enzymes in human breast cancer tissue. Clinical Cancer Research, 6, 3657-3661.

Alterations in polyamine catabolic enzymes in human breast cancer tissue. / Wallace, H M ; Duthie, J ; Evans, D M ; Lamond, S ; Nicoll, K M ; Heys, S D .

In: Clinical Cancer Research, Vol. 6, 2000, p. 3657-3661.

Research output: Contribution to journalArticle

Wallace, HM, Duthie, J, Evans, DM, Lamond, S, Nicoll, KM & Heys, SD 2000, 'Alterations in polyamine catabolic enzymes in human breast cancer tissue', Clinical Cancer Research, vol. 6, pp. 3657-3661.
Wallace HM, Duthie J, Evans DM, Lamond S, Nicoll KM, Heys SD. Alterations in polyamine catabolic enzymes in human breast cancer tissue. Clinical Cancer Research. 2000;6:3657-3661.
Wallace, H M ; Duthie, J ; Evans, D M ; Lamond, S ; Nicoll, K M ; Heys, S D . / Alterations in polyamine catabolic enzymes in human breast cancer tissue. In: Clinical Cancer Research. 2000 ; Vol. 6. pp. 3657-3661.
@article{f30708c491644af4b53b94c4c8abd19d,
title = "Alterations in polyamine catabolic enzymes in human breast cancer tissue",
abstract = "High concentrations of acetyl polyamines have been observed in human breast cancer compared with the equivalent normal tissue, however, no explanation as to the reason for the increases has been proposed. In this study, we show that changes in the enzymes responsible for the breakdown of acetyl polyamines occur in breast cancer tissue. Spermidine/spermine N-1-acetyltranferase, the first and rate-limiting enzyme in polyamine catabolism, is increased in the tumor tissue whereas polyamine oxidase (PAO) is decreased. The changes in PAO correlate with prognostic factors, and activity decreases as the size and histological grade of tumors increase. The metabolism of polyamines by PAO generates locally high concentrations of hydrogen peroxide, a known inducer of apoptosis; thus, low PAO activity may contribute to the low level of apoptosis seen in tumor cells. Therefore, drugs that induce PAO activity may be a novel means of attacking tumor cells.",
keywords = "CELLS, DERIVATIVES, ACETYLATION",
author = "Wallace, {H M} and J Duthie and Evans, {D M} and S Lamond and Nicoll, {K M} and Heys, {S D}",
year = "2000",
language = "English",
volume = "6",
pages = "3657--3661",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",

}

TY - JOUR

T1 - Alterations in polyamine catabolic enzymes in human breast cancer tissue

AU - Wallace, H M

AU - Duthie, J

AU - Evans, D M

AU - Lamond, S

AU - Nicoll, K M

AU - Heys, S D

PY - 2000

Y1 - 2000

N2 - High concentrations of acetyl polyamines have been observed in human breast cancer compared with the equivalent normal tissue, however, no explanation as to the reason for the increases has been proposed. In this study, we show that changes in the enzymes responsible for the breakdown of acetyl polyamines occur in breast cancer tissue. Spermidine/spermine N-1-acetyltranferase, the first and rate-limiting enzyme in polyamine catabolism, is increased in the tumor tissue whereas polyamine oxidase (PAO) is decreased. The changes in PAO correlate with prognostic factors, and activity decreases as the size and histological grade of tumors increase. The metabolism of polyamines by PAO generates locally high concentrations of hydrogen peroxide, a known inducer of apoptosis; thus, low PAO activity may contribute to the low level of apoptosis seen in tumor cells. Therefore, drugs that induce PAO activity may be a novel means of attacking tumor cells.

AB - High concentrations of acetyl polyamines have been observed in human breast cancer compared with the equivalent normal tissue, however, no explanation as to the reason for the increases has been proposed. In this study, we show that changes in the enzymes responsible for the breakdown of acetyl polyamines occur in breast cancer tissue. Spermidine/spermine N-1-acetyltranferase, the first and rate-limiting enzyme in polyamine catabolism, is increased in the tumor tissue whereas polyamine oxidase (PAO) is decreased. The changes in PAO correlate with prognostic factors, and activity decreases as the size and histological grade of tumors increase. The metabolism of polyamines by PAO generates locally high concentrations of hydrogen peroxide, a known inducer of apoptosis; thus, low PAO activity may contribute to the low level of apoptosis seen in tumor cells. Therefore, drugs that induce PAO activity may be a novel means of attacking tumor cells.

KW - CELLS

KW - DERIVATIVES

KW - ACETYLATION

M3 - Article

VL - 6

SP - 3657

EP - 3661

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

ER -